The Department of Health and Social Care has published its new Pandemic Preparedness Strategy ,alongside the UK Government's response to the Covid-19 Inquiry Module 2 report.
Features
Improving HER2 classification with molecular testing
Recent changes in HER2 scoring in breast cancer have further complicated an already challenging diagnosis. Vinicio Tassani examines current workflows and makes the case for adding molecular testing to the mix.
Using rapid diagnostics to streamline CPE infection control
University Hospitals Coventry and Warwickshire NHS Trust recently saw a cross-team collaboration which led to the successful rollout of near-patient CPE testing with rapid PCR diagnostics for stroke patients. Consultant microbiologist Dr Natasha Ratnaraja and clinical scientist infection specialist Katie Jones describe how this new technology has...
Products
New LIAISON tuberculosis assay improves efficiency and productivity
Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.
Menarini introduces Coyote FlashDetect PCR device range
Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.
QIAGEN unveils QIAsymphony Connect at AMP 2025
QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
Analytica 2026
Messe München, Munich, Germany
24-27 March, 2026
Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
7 April, 2026
Microbiology Society Annual Conference 2026
ICC Belfast, Northern Ireland
13 - 16 April, 2026
UK NEQAS webinar: Introduction to Mohs Procedure
Online
15 April, 2026
39th International Symposium on Technical Innovations in Laboratory Hematology
Edinburgh International Convention Centre
17-19 April, 2026